BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 17230510)

  • 21. Endometrial cancer risk is associated with variants of the mismatch repair genes MLH1 and MSH2.
    Beiner ME; Rosen B; Fyles A; Harley I; Pal T; Siminovitch K; Zhang S; Sun P; Narod SA
    Cancer Epidemiol Biomarkers Prev; 2006 Sep; 15(9):1636-40. PubMed ID: 16985024
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Distinction of hereditary nonpolyposis colorectal cancer and sporadic microsatellite-unstable colorectal cancer through quantification of MLH1 methylation by real-time PCR.
    Bettstetter M; Dechant S; Ruemmele P; Grabowski M; Keller G; Holinski-Feder E; Hartmann A; Hofstaedter F; Dietmaier W
    Clin Cancer Res; 2007 Jun; 13(11):3221-8. PubMed ID: 17545526
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of MLH1, MSH2 and MSH6 in the development of multiple colorectal cancers.
    Lawes DA; Pearson T; Sengupta S; Boulos PB
    Br J Cancer; 2005 Aug; 93(4):472-7. PubMed ID: 16106253
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The MLH1 polymorphism rs1800734 and risk of endometrial cancer with microsatellite instability.
    Russell H; Kedzierska K; Buchanan DD; Thomas R; Tham E; Mints M; Keränen A; Giles GG; Southey MC; Milne RL; Tomlinson I; Church D; Spurdle AB; O'Mara TA; Lewis A
    Clin Epigenetics; 2020 Jul; 12(1):102. PubMed ID: 32641106
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Further evidence for heritability of an epimutation in one of 12 cases with MLH1 promoter methylation in blood cells clinically displaying HNPCC.
    Morak M; Schackert HK; Rahner N; Betz B; Ebert M; Walldorf C; Royer-Pokora B; Schulmann K; von Knebel-Doeberitz M; Dietmaier W; Keller G; Kerker B; Leitner G; Holinski-Feder E
    Eur J Hum Genet; 2008 Jul; 16(7):804-11. PubMed ID: 18301449
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hypermethylation of the MLH1 promoter with concomitant absence of transcript and protein occurs in small patches of crypt cells in unaffected mucosa from sporadic colorectal carcinoma.
    Nuovo GJ; Nakagawa H; Sotamaa K; Chapelle Ade L
    Diagn Mol Pathol; 2006 Mar; 15(1):17-23. PubMed ID: 16531764
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Methylation pattern of different regions of the MLH1 promoter and silencing of gene expression in hereditary and sporadic colorectal cancer.
    Menigatti M; Di Gregorio C; Borghi F; Sala E; Scarselli A; Pedroni M; Foroni M; Benatti P; Roncucci L; Ponz de Leon M; Percesepe A
    Genes Chromosomes Cancer; 2001 Aug; 31(4):357-61. PubMed ID: 11433526
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A MLH1 polymorphism that increases cancer risk is associated with better outcome in sporadic colorectal cancer.
    Nejda N; Iglesias D; Moreno Azcoita M; Medina Arana V; González-Aguilera JJ; Fernández-Peralta AM
    Cancer Genet Cytogenet; 2009 Sep; 193(2):71-7. PubMed ID: 19665066
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Epigenetic silencing of AXIN2 in colorectal carcinoma with microsatellite instability.
    Koinuma K; Yamashita Y; Liu W; Hatanaka H; Kurashina K; Wada T; Takada S; Kaneda R; Choi YL; Fujiwara SI; Miyakura Y; Nagai H; Mano H
    Oncogene; 2006 Jan; 25(1):139-46. PubMed ID: 16247484
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Microsatellite instability and epigenetic inactivation of MLH1 and outcome of patients with endometrial carcinomas of the endometrioid type.
    Zighelboim I; Goodfellow PJ; Gao F; Gibb RK; Powell MA; Rader JS; Mutch DG
    J Clin Oncol; 2007 May; 25(15):2042-8. PubMed ID: 17513808
    [TBL] [Abstract][Full Text] [Related]  

  • 31. DNA hypermethylation in the normal colonic mucosa of patients with colorectal cancer.
    Kawakami K; Ruszkiewicz A; Bennett G; Moore J; Grieu F; Watanabe G; Iacopetta B
    Br J Cancer; 2006 Feb; 94(4):593-8. PubMed ID: 16421593
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association between MLH1 -93G>a polymorphism and risk of colorectal cancer.
    Wang T; Liu Y; Sima L; Shi L; Wang Z; Ni C; Zhang Z; Wang M
    PLoS One; 2012; 7(11):e50449. PubMed ID: 23226285
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Promoter methylation status of the MGMT, hMLH1, and CDKN2A/p16 genes in non-neoplastic mucosa of patients with and without colorectal adenomas.
    Ye C; Shrubsole MJ; Cai Q; Ness R; Grady WM; Smalley W; Cai H; Washington K; Zheng W
    Oncol Rep; 2006 Aug; 16(2):429-35. PubMed ID: 16820927
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MGMT germline polymorphism is associated with somatic MGMT promoter methylation and gene silencing in colorectal cancer.
    Ogino S; Hazra A; Tranah GJ; Kirkner GJ; Kawasaki T; Nosho K; Ohnishi M; Suemoto Y; Meyerhardt JA; Hunter DJ; Fuchs CS
    Carcinogenesis; 2007 Sep; 28(9):1985-90. PubMed ID: 17621591
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mutually exclusive promoter hypermethylation patterns of hMLH1 and O6-methylguanine DNA methyltransferase in colorectal cancer.
    Fox EJ; Leahy DT; Geraghty R; Mulcahy HE; Fennelly D; Hyland JM; O'Donoghue DP; Sheahan K
    J Mol Diagn; 2006 Feb; 8(1):68-75. PubMed ID: 16436636
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Histologic features distinguish microsatellite-high from microsatellite-low and microsatellite-stable colorectal carcinomas, but do not differentiate germline mutations from methylation of the MLH1 promoter.
    Yearsley M; Hampel H; Lehman A; Nakagawa H; de la Chapelle A; Frankel WL
    Hum Pathol; 2006 Jul; 37(7):831-8. PubMed ID: 16784982
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pathologic features of endometrial carcinoma associated with HNPCC: a comparison with sporadic endometrial carcinoma.
    Broaddus RR; Lynch HT; Chen LM; Daniels MS; Conrad P; Munsell MF; White KG; Luthra R; Lu KH
    Cancer; 2006 Jan; 106(1):87-94. PubMed ID: 16323174
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association of colonic and endometrial carcinomas in Portuguese families with hereditary nonpolyposis colorectal carcinoma significantly increases the probability of detecting a pathogenic mutation in mismatch repair genes, primarily the MSH2 gene.
    Lage PA; Albuquerque C; Sousa RG; Cravo ML; Salazar M; Francisco I; Maia L; Claro I; Suspiro A; Rodrigues P; Raposo H; Fidalgo PA; Nobre-Leitão C
    Cancer; 2004 Jul; 101(1):172-7. PubMed ID: 15222003
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular analysis of imperative polymorphisms of MLH1 gene in sporadic colorectal cancer.
    Milanizadeh S; Khanyaghma M; Haghighi MM; Mohebbi S; Damavand B; Almasi S; Azimzadeh P; Zali M
    Cancer Biomark; 2013 Jan; 13(6):427-32. PubMed ID: 24595079
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genetic and epigenetic modification of MLH1 accounts for a major share of microsatellite-unstable colorectal cancers.
    Kuismanen SA; Holmberg MT; Salovaara R; de la Chapelle A; Peltomäki P
    Am J Pathol; 2000 May; 156(5):1773-9. PubMed ID: 10793088
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.